Ilaria Floris

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 24

Top Venues

International journal of molecular sciences

Life (Basel, Switzerland)

Journal of inflammation research

Cancers

Labo'Life France

International PhD School in Biomolecular and Biotechnological Sciences in Sassari and long term visitor/honorary contract (04/2011 – 07/2013) at the laboratory of Vascular Pathology and Regeneration, Section of Regenerative Medicine, University of Bristol (UK) (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Labo'Life France

France

Head of PreClinical Developement :: Preclinical & Clinical Development and Regulatory Afairs

Labo'Life France

France

Scientific assistant :: Preclinical & Clinical Development and Regulatory Affairs

Education History

Italy

PHD

Publications

Camille Jacques, Flora Marchand, Mathias Chatelais, Adrien Brulefert, Ilaria Floris
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV ® Active Ingredients. Life (Basel, Switzerland) 14 (1) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Adrien Brulefert, Ilaria Floris
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV ® Active Ingredients. Life (Basel, Switzerland) 14 (1) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Adrien Brulefert, Mathieu Riffault, Ilaria Floris
In Vitro Study of Interleukin-6 when Used at Low Dose and Ultra-Low Dose in Micro-Immunotherapy. Life (Basel, Switzerland) 14 (3) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Virginie Albinet, Claire Coustal, Ilaria Floris
The Micro-Immunotherapy Medicine 2LPAPI ® Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells. Cancers 16 (7) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Adrien Brulefert, Mathieu Riffault, Ilaria Floris
In Vitro Study of Interleukin-6 when Used at Low Dose and Ultra-Low Dose in Micro-Immunotherapy. Life (Basel, Switzerland) 14 (3) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Virginie Albinet, Claire Coustal, Ilaria Floris
The Micro-Immunotherapy Medicine 2LPAPI ® Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells. Cancers 16 (7) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Ilaria Floris
Actives from the Micro-Immunotherapy Medicine 2LMIREG ® Reduce the Expression of Cytokines and Immune-Related Markers Including Interleukin-2 and HLA-II While Modulating Oxidative Stress and Mitochondrial Function. Journal of inflammation research 17 (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Virginie Albinet, Claire Coustal, Ilaria Floris
The Micro-Immunotherapy Medicine 2LPAPI ® Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells. Cancers 16 (7) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Ilaria Floris
Actives from the Micro-Immunotherapy Medicine 2LMIREG ® Reduce the Expression of Cytokines and Immune-Related Markers Including Interleukin-2 and HLA-II While Modulating Oxidative Stress and Mitochondrial Function. Journal of inflammation research 17 (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Adrien Brulefert, Ilaria Floris
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV ® Active Ingredients. Life (Basel, Switzerland) 14 (1) (2024)
Camille Jacques, Ilaria Floris
How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March. International journal of molecular sciences 24 (2) (2023)
Camille Jacques, Ilaria Floris
How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March. International journal of molecular sciences 24 (2) (2023)
Camille Jacques, Ilaria Floris
How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March. International journal of molecular sciences 24 (2) (2023)
Maria Del Mar Ferrà-Cañellas, Marta Munar-Bestard, Ilaria Floris, Joana Maria Ramis, Marta Monjo, Laura Garcia-Sureda
A Sequential Micro-Immunotherapy Medicine Increases Collagen Deposition in Human Gingival Fibroblasts and in an Engineered 3D Gingival Model under Inflammatory Conditions. International journal of molecular sciences 24 (13) (2023)
Camille Jacques, Ilaria Floris
How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March. International journal of molecular sciences 24 (2) (2023)
Camille Jacques, Mathias Chatelais, Karim Fekir, Adrien Brulefert, Ilaria Floris
The Unitary Micro-Immunotherapy Medicine Interferon-γ (4 CH) Displays Similar Immunostimulatory and Immunomodulatory Effects than Those of Biologically Active Human Interferon-γ on Various Cell Types. International journal of molecular sciences 23 (4) (2022)
Camille Jacques, Ilaria Floris
Special Focus on the Cellular Anti-Inflammatory Effects of Several Micro-Immunotherapy Formulations: Considerations Regarding Intestinal-, Immune-Axis-Related- and Neuronal-Inflammation Contexts. Journal of inflammation research 15 (2022)
Camille Jacques, Irene Marchesi, Francesco Paolo Fiorentino, Mathias Chatelais, Nicoletta Libera Lilli, Kurt Appel, Beatrice Lejeune, Ilaria Floris
A Micro-Immunotherapy Sequential Medicine MIM-seq Displays Immunomodulatory Effects on Human Macrophages and Anti-Tumor Properties towards In Vitro 2D and 3D Models of Colon Carcinoma and in an In Vivo Subcutaneous Xenograft Colon Carcinoma Model. International journal of molecular sciences 23 (11) (2022)
Camille Jacques, Ilaria Floris
Special Focus on the Cellular Anti-Inflammatory Effects of Several Micro-Immunotherapy Formulations: Considerations Regarding Intestinal-, Immune-Axis-Related- and Neuronal-Inflammation Contexts. Journal of inflammation research 15 (2022)
Camille Jacques, Ilaria Floris, Béatrice Lejeune
Ultra-Low Dose Cytokines in Rheumatoid Arthritis, Three Birds with One Stone as the Rationale of the 2LARTH® Micro-Immunotherapy Treatment. International journal of molecular sciences 22 (13) (2021)
Camille Jacques, Mathias Chatelais, Karim Fekir, Louis Fauconnier, Manon Mellier, Dieudonnée Togbe, Ilaria Floris
The Micro-Immunotherapy Medicine 2LEID Exhibits an Immunostimulant Effect by Boosting Both Innate and Adaptive Immune Responses. International journal of molecular sciences 23 (1) (2021)
Ilaria Floris, Víctor García-González, Belen Palomares, Kurt Appel, Beatrice Lejeune
The Micro-Immunotherapy Medicine 2LARTH® Reduces Inflammation and Symptoms of Rheumatoid Arthritis In Vivo. International journal of rheumatology 2020 (2020)
Ilaria Floris, Thorsten Rose, Juan Antonio Collado Rojas, Kurt Appel, Camille Roesch, Beatrice Lejeune
Pro-Inflammatory Cytokines at Ultra-Low Dose Exert Anti-Inflammatory Effect In Vitro: A Possible Mode of Action Involving Sub-Micron Particles? Dose-response : a publication of International Hormesis Society 18 (4) (2020)
Ilaria Floris, Pauline Chenuet, Dieudonnée Togbe, Christelle Volteau, Beatrice Lejeune
Potential Role of the Micro-Immunotherapy Medicine 2LALERG in the Treatment of Pollen-Induced Allergic Inflammation. Dose-response : a publication of International Hormesis Society 18 (1) (2020)

Ilaria Floris.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ilaria Floris